The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 02, 2014

Filed:

Jul. 10, 2009
Applicants:

Fumiyoshi Okano, Kanagawa, JP;

Masaki Shimizu, Ehime, JP;

Takanori Saito, Kanagawa, JP;

Inventors:

Fumiyoshi Okano, Kanagawa, JP;

Masaki Shimizu, Ehime, JP;

Takanori Saito, Kanagawa, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2006.01); A61K 38/00 (2006.01); C07K 7/06 (2006.01); C07K 14/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); A61K 31/711 (2006.01); A61K 39/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 14/47 (2013.01); A61K 31/711 (2013.01); A61K 39/0011 (2013.01); G01N 33/57415 (2013.01); G01N 33/57426 (2013.01); A61K 38/00 (2013.01); A61K 2039/55566 (2013.01);
Abstract

An immunity-inducing agent comprising as an effective ingredient(s) at least one polypeptide selected from the following polypeptides, the polypeptide(s) having an immunity-inducing activity/activities, or as an effective ingredient(s) a recombinant vector(s) which comprise(s) a polynucleotide(s) encoding the polypeptide(s) and is/are capable of expressing the polypeptide(s) in vivo can be used for therapy and/or prophylaxis of cancer: (a) a polypeptide consisting essentially of not less than 7 consecutive amino acids in any one of the amino acid sequences shown in the odd number IDs of SEQ ID NOs:3 to 95 in SEQUENCE LISTING; (b) a polypeptide having a sequence identity of not less than 90% with the polypeptide (a) and consisting essentially of not less than 7 amino acids; and (c) a polypeptide comprising the polypeptide (a) or (b) as a partial sequence thereof. Further, since the above polypeptide(s) react(s) with antibodies existing specifically in serum of a cancer patient, it is possible to detect cancer in a living body by measuring the antibodies in a sample.


Find Patent Forward Citations

Loading…